Related Experiment Videos
Cholesterol metabolism in infant rats, effect of 6-hydroxydopamine and guanfacine
1Department of Obstetrics, University of British Columbia, Vancouver, Canada.
Insights
Antihypertensive drugs affecting beta-adrenergic activity altered cholesterol metabolism in infant rats. These drugs increased plasma cholesterol and decreased key enzyme activity, particularly in younger animals.
Area of Science:
- Pharmacology
- Biochemistry
- Developmental Biology
Background:
- Beta-adrenergic signaling plays a role in metabolic regulation.
- Cholesterol homeostasis is crucial for development and health.
- Antihypertensive medications can have off-target effects on metabolic pathways.
Purpose of the Study:
- To investigate the impact of beta-adrenergic inhibiting drugs on cholesterol metabolism in infant and weaned rats.
- To determine age-dependent effects of 6-hydroxydopamine and guanfacine on lipid metabolism.
Main Methods:
- Infant (10-16 days) and weaned (older than 18 days) rats were administered 6-hydroxydopamine or guanfacine.
- Animals were sacrificed 4 days post-treatment.
- Plasma cholesterol levels were measured.
- Hepatic activity of 3-hydroxy-3-methylglutaryl CoA reductase and acylcholesterol acyl CoA transferase was assessed.
Main Results:
- Both drugs significantly increased plasma cholesterol in infant rats.
- Hepatic 3-hydroxy-3-methylglutaryl CoA reductase activity decreased in infant rats post-treatment.
- These metabolic changes were not observed in weaned rats.
- Acylcholesterol acyl CoA transferase activity decreased in both age groups.
Conclusions:
- Antihypertensive drugs targeting beta-adrenergic and alpha 2-receptors can disrupt cholesterol metabolism.
- Infant animals exhibit a heightened sensitivity to these metabolic alterations.
- These findings highlight potential age-specific risks associated with certain antihypertensive therapies.
Abstract:
Infant rats (10-16 days) and weaned animals (older than 18 days) were treated with drugs inhibiting beta-adrenergic activity and were sacrificed 4 days later. 6-Hydroxydopamine acts on postsympathetic nerve fibres, and guanfacine stimulates alpha 2-receptors. Both drugs caused a rise in plasma cholesterol and a decrease in hepatic 3-hydroxy-3-methylglutaryl CoA reductase activity in infant but not in weaned animals. The activity of acylcholesterol acyl CoA transferase, on the other hand, was decreased after drug administration. Thus, both antihypertensive drugs may cause changes in cholesterol metabolism, especially in infant animals.